InvestorsHub Logo
Followers 168
Posts 3183
Boards Moderated 0
Alias Born 11/03/2014

Re: dstock07734 post# 590344

Tuesday, 05/02/2023 11:21:17 PM

Tuesday, May 02, 2023 11:21:17 PM

Post# of 731271
dstock07734, I don’t see any connection between DCVax-001 and DCVax-L, or DCVax Direct. DCVax-001 is being developed to treat HIV.

DCVax-001 is a recombinant protein vaccine, composed of a fusion protein containing a human monoclonal antibody specific for the dendritic cell receptor, DEC-205 (CD205), and the HIV gag p24 protein.

The study is being conducted at Rockefeller University in New York City. I do not see any other locations for this trial.
Bullish
Bullish
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News